featured
Impact of Anti-VEGF Biosimilars on Patient and Overall Healthcare Costs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Biosimilar Paradox: How Anti-VEGF Biosimilars will Increase Patient and Overall Healthcare Costs
Ophthalmology 2023 Apr 26;[EPub Ahead of Print], C Zhang, S Friedman, P Mruthyunjaya, R ParikhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.